Investment
Features
FeesSafety
Academy
More
Pluang+

Kanzhun Ltd. rated buy as AI boosts its recruitment platform's growth potential and monetization.

Analyst Insights
11 Jul 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Kanzhun Ltd. (BZ) is rated a buy due to the underestimated positive impact of AI on its recruitment platform. The company's two-sided scale and direct chat model create strong network effects, making it hard for competitors to replicate. Growth is expected from converting more of its 36.8 million verified enterprise users into paying customers, especially among SMEs and blue-collar employers. Trading at 10x next twelve months PE with mid-teens earnings growth, Kanzhun offers about 50% upside over five years if it successfully monetizes and leverages AI improvements.

More News

Standard Chartered keeps Bitcoin price target at $100K by 2026 despite Strategy's Bitcoin sales causing market jitters.

Standard Chartered keeps Bitcoin price target at $100K by 2026 despite Strategy's Bitcoin sales causing market jitters.

Standard Chartered maintains its Bitcoin price forecast of $100,000 by the end of 2026, attributing recent market declines to Strategy Inc.'s communication issues rather than Bitcoin's fundamentals. Strategy, the largest institutional Bitcoin holder ...

Market News
Bullish
4 hours ago
InterDigital grows recurring revenue 13%, maintains dividend, and expands into video streaming for future growth.

InterDigital grows recurring revenue 13%, maintains dividend, and expands into video streaming for future growth.

InterDigital reported a 13% increase in annualized recurring revenue to $567.2 million, driven by an 18% rise in smartphone revenue and diversification into consumer electronics, IoT, and automotive sectors. Despite near-term margin pressure from LG ...

Market News
Bullish
4 hours ago
Futura Medical partners with MPG for US sales and reports positive trial results for female sexual health product WSD4000.

Futura Medical partners with MPG for US sales and reports positive trial results for female sexual health product WSD4000.

Futura Medical has formed a new US commercial partnership with Market Performance Group (MPG) to manage sales, marketing, and distribution of its Eroxon product, shifting from a traditional licensing model to a more active commercial strategy. The co...

Market News
Bullish
4 hours ago
Pfizer undervalued with 7% dividend yield and strong growth from new products post-Seagen acquisition

Pfizer undervalued with 7% dividend yield and strong growth from new products post-Seagen acquisition

Pfizer is currently undervalued, trading at just over 8 times its projected 2026 earnings and offering a 7% dividend yield. Its core business, excluding COVID-related drugs, grew 7% in Q1, while new products, especially from its acquisition of Seagen...

Analyst Insights
Bullish
4 hours ago
Haverty Furniture shows resilience with 4.1% sales growth despite housing market challenges.

Haverty Furniture shows resilience with 4.1% sales growth despite housing market challenges.

Haverty Furniture (HVT) has demonstrated resilience beyond typical housing market dependence by targeting affluent customers, which provides stability amid economic fluctuations. The company reported a 4.1% increase in net sales and a strong gross ma...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App